HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samer Mansour Selected Research

Coronary Disease (Coronary Heart Disease)

1/2023Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
12/2021Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Samer Mansour Research Topics

Disease

15Myocardial Infarction
01/2023 - 04/2006
14ST Elevation Myocardial Infarction
01/2023 - 10/2010
8Coronary Artery Disease (Coronary Atherosclerosis)
07/2023 - 08/2013
7Hemorrhage
10/2023 - 08/2005
7Infarction (Infarctions)
11/2020 - 08/2005
6Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 11/2016
6Stroke (Strokes)
01/2023 - 12/2016
5Atrial Fibrillation
10/2023 - 03/2020
5COVID-19
01/2022 - 01/2020
5Cardiomyopathies (Cardiomyopathy)
10/2017 - 04/2013
4Acute Coronary Syndrome
10/2023 - 10/2017
4Heart Failure
07/2023 - 04/2010
4Ischemia
01/2022 - 11/2012
4Thrombosis (Thrombus)
01/2022 - 11/2020
2Respiratory Insufficiency (Respiratory Failure)
04/2024 - 01/2020
2Coronary Disease (Coronary Heart Disease)
01/2023 - 12/2021
2Hyperplasia
01/2022 - 01/2016
2Left Ventricular Dysfunction
11/2020 - 01/2011
2Death (Near-Death Experience)
11/2020 - 11/2016
2Hypoxia (Hypoxemia)
01/2020 - 11/2012
2Myocardial Ischemia (Ischemic Heart Diseases)
11/2014 - 10/2010
1Hypertension (High Blood Pressure)
07/2023
1Diabetes Mellitus
01/2022
1Vascular System Injuries
01/2022
1Transient Ischemic Attack
12/2021
1Virus Diseases (Viral Diseases)
01/2020
1Cytokine Release Syndrome
01/2020
1Peripheral Arterial Disease
11/2017
1Pheochromocytoma
10/2017
1Paraganglioma (Paragangliomas)
10/2017
1Takotsubo Cardiomyopathy
10/2017
1Pathologic Constriction (Stenosis)
11/2016
1AIDS-Related Complex (ARC)
01/2016
1Inflammation (Inflammations)
11/2012
1Intraoperative Complications
08/2005

Drug/Important Bio-Agent (IBA)

32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
10/2023 - 01/2018
3EverolimusFDA Link
11/2019 - 11/2016
3dimemorfan (AT 17)IBA
11/2018 - 10/2010
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2023 - 10/2022
2CalciumIBA
01/2021 - 01/2018
2Fluorocarbon PolymersIBA
11/2019 - 12/2016
2CobaltIBA
11/2019 - 12/2016
2ChromiumIBA
11/2019 - 12/2016
2omega-Chloroacetophenone (Mace)IBA
10/2017 - 11/2016
2Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 11/2016
2Phenobarbital (Luminal)FDA Link
01/2007 - 04/2006
1Prescription DrugsIBA
12/2023
1APTIBA
10/2023
1LipidsIBA
07/2023
1Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2022
1VaccinesIBA
01/2022
1insulin receptor-related receptor (IRR)IBA
09/2021
1SolutionsIBA
06/2021
1AntithrombinsIBA
11/2020
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2020
1Mitochondrial Permeability Transition PoreIBA
06/2019
1celastrolIBA
06/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2018
1Dihydrotachysterol (AT 10)IBA
01/2018
1TicagrelorIBA
01/2018
13-Iodobenzylguanidine (Iobenguane)IBA
10/2017
1CatecholaminesIBA
10/2017
1Cytidine Monophosphate (CMP)IBA
11/2014
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
11/2012
1TransferasesIBA
11/2012
1Glycoproteins (Glycoprotein)IBA
12/2011
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2010
1Heparin (Liquaemin)FDA LinkGeneric
10/2010
1Enoxaparin (Lovenox)FDA LinkGeneric
10/2010
1Glucose (Dextrose)FDA LinkGeneric
08/2005

Therapy/Procedure

17Therapeutics
10/2023 - 04/2010
17Percutaneous Coronary Intervention
10/2023 - 12/2011
14Stents
01/2022 - 08/2005
11Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2023 - 01/2011
5Drug-Eluting Stents
01/2023 - 11/2016
3Treatment Delay
10/2022 - 01/2017
2Critical Care (Surgical Intensive Care)
01/2022 - 01/2021
2Perioperative Period
01/2022 - 10/2013
2Injections
04/2013 - 01/2011
2Cell- and Tissue-Based Therapy (Cell Therapy)
11/2012 - 10/2010
2Transplantation
11/2012 - 10/2010
1Heart-Assist Devices
04/2024
1Oxygenators
04/2024
1Vascular Surgical Procedures
01/2022
1Secondary Prevention
10/2021
1Ambulatory Care (Outpatient Care)
01/2020
1Cardiac Rehabilitation
01/2020
1Surgical Amputation (Amputations)
11/2017
1Heart Transplantation (Grafting, Heart)
11/2014
1Thrombolytic Therapy
10/2010
1Cardiopulmonary Bypass (Heart-Lung Bypass)
08/2005